Valerie Dodane

Valerie Dodane currently serves as Vice President of Product Strategy at Boston Pharmaceuticals, overseeing New Product Planning and Medical Affairs since March 2021. Previously, Dodane held the position of Vice President of Medical Affairs at GSK from October 2015 to March 2021, where responsibilities included leading medical initiatives for products such as Nucala for Eosinophilic Granulomatosis with PolyAngiitis. Earlier roles include US Medical Affairs Lead for sirukumab at Allergan and Senior Director of Medical Affairs across several therapeutic areas. Dodane's extensive career in the pharmaceutical industry began at Bristol-Myers Squibb, where a range of positions in Medical Affairs and project management were held from 2002 to 2013. Prior experience includes roles at West Pharmaceutical Services and a Visiting Fellow position at the National Institutes of Health. Dodane earned a Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology from Pierre and Marie Curie University.